Skip to main content
Figure 1 | Journal of Hematology & Oncology

Figure 1

From: Targeted therapy in lymphoma

Figure 1

The PI3K/Akt signaling pathway. Reprinted with permission from Altman JK, Platanias LC: Exploiting the mammalian target of rapamycin pathway in hematologic malignancies. Curr Opin Hematol. 2008, 15:88-94.

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us